Medicinal chemistry of ρ GABA C receptors

Future Medicinal Chemistry

Volumn 3, Issue 2, 2011, Pages 197-209

  Ng, Clarissa Kl ^a   Kim, Hye Lim ^a   Gavande, Navnath ^a   Yamamoto, Izumi ^a   Kumar, Rohan J ^a   Mewett, Kenneth N ^a   Johnston, Graham Ar ^a   Hanrahan, Jane R ^a   Chebib, Mary ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

(1,2,5,6 TETRAHYDROPYRIDINE 4 YL)METHYLPHOSPHINIC ACID; 3 (AMINOCYCLOPENTANE)METHYLPHOSPHINIC ACID; 3 AMINOPROPYLBUTYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID C RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 4 AMINOCYCLOPENT 1 ENYLCARBOXYLIC ACID; AMINOPROPYLPHOSPHINIC ACID; BACLOFEN; BICUCULLINE; GABOXADOL; LORECLEZOLE; MUSCIMOL; PHOSPHINIC ACID DERIVATIVE; PICROTOXIN; RHO AMINOBUTYRIC ACID C RECEPTOR; ROD 188; THYROTROPIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTINOCICEPTION; BLOOD VESSEL PERMEABILITY; BRAIN REGION; COGNITION; COGNITIVE DEFECT; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; EVOKED RESPONSE; HUMAN; IMMUNOHISTOCHEMISTRY; ISOMER; LEARNING; MEMORY; MILD COGNITIVE IMPAIRMENT; MOLECULAR WEIGHT; MYOPIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SLEEP DISORDER; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION; THYROTROPIN RELEASE;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MOLECULAR STRUCTURE; RECEPTORS, GABA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79951595251     PISSN: 17568919     EISSN: None     Source Type: Journal    
DOI: 10.4155/fmc.10.286     Document Type: Review

References (146)

1. Crittenden DL, Chebib M, Jordan MJT. Stabilization of zwitterions in solution: GABA analogues. J. Phys. Chem. A 109(18), 4195-4201 (2005). (Pubitemid 40750877)
2. Kalueff A, Nutt DJ. Role of GABA in memory and anxiety. Depress. Anxiety 4, 100-110 (1997). (Pubitemid 27237372)
3. Gibbs ME, Johnston GAR. Opposing roles for GABAA and GABAC receptors in short-term memory formation in young chicks. Neurosci. 131, 567-576 (2005). (Pubitemid 40261213)
4. Jacobson LH, Kelly PH, Bettler B, Kaupmann K, Cryan JF. Specific roles of GABAB(1) receptor isoforms in cognition. Behav. Brain Res. 181, 158-162 (2007). (Pubitemid 46765008)
5. Lewis DA, Cho RY, Carter CS et al. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am. J. Psychiatry 165, 1585-1593 (2008).
6. Binns KE, Salt TE. Different roles for GABAA and GABAB receptors in visual processing in the rat superior colliculus. J. Physiol. 504, 629-639 (1997). (Pubitemid 27493861)
7. Enz R, Brandstatter JH, Hartveit E, Wässle H, Bormann J. Expression of GABA receptor r1 and r2 subunits in the retina and brain of the rat. Eur. J. Neurosci. 7, 1495-1501 (1995).
8. Enz R, Cutting GR. Molecular composition of GABAC receptors. Vision Res. 38, 1431-1441 (1998).
9. Sernagor E, Young C, Eglen S. Developmental modulation of retinal wave dynamics. Shedding light on the GABA saga. J. Neurosci. 23, 7621-7629 (2003). (Pubitemid 37034079)
10. Storer RJ, Akerman S, Goadsby PJ. GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complex. Br. J. Pharmacol. 134, 896-904 (2001). (Pubitemid 33016162)
11. Knabl J, Witschi R, Hösl K et al. Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 451, 330-334 (2008).
12. Neto FL, Ferreira-Gomes J, Castro-Lopes JM. Distribution of GABA receptors in the thalamus and their involvement in nociception. Adv. Pharmacol. 54, 29-51 (2006).
13. Lancel M, Crönlein Tam, Faulhaber J. Role of GABAA receptors in sleep regulation - differential effects of muscimol and midazolam on sleep in rats. Neuropsychopharmacol. 15, 63-74 (1996). (Pubitemid 26233392)
14. Gottesmann C. GABA mechanism and sleep. Neurosci. 111, 231-239 (2002).
15. Wafford KA, Ebert B. Gaboxadol - a new awakening in sleep. Curr. Opin. Pharmacol. 6, 30-36 (2006). (Pubitemid 43103817)
16. Defeudis FV. γ-aminobutyric acid and cardiovascular function. Experientia 39, 845-849 (1983).
17. Defeudis FV. Involvement of γ-aminobutyric acid in cardiovascular regulation. Trends Pharmacol. Sci. 4, 356-358 (1983).
18. Jones-Davis DM, Macdonald RL. GABAA receptor function and pharmacology in epilepsy and status epilepticus. Curr. Opin. Pharmacol. 3, 12-18 (2003). (Pubitemid 36131321)
19. Palma E, Spinelli G, Torchia G et al. Abnormal GABAA receptors from the human epileptic hippocampal subiculum microtransplanted to Xenopus oocytes. Proc. Natl Acad. Sci. USA 102, 2514-2518 (2005). (Pubitemid 40279408)
20. Möhler H. GABAA receptors in central nervous system disease: anxiety, epilepsy and insomnia. J. Recept. Signal Transduct. Res. 26, 731-740 (2006). (Pubitemid 44849915)
21. Morris HV, Dawson GR, Reynolds DS, Atack JR, Stephens DN. Both a2 and a3 GABAA receptor subtypes mediate the anxiolytic properties of benzodiazepine site ligands in the conditioned emotional response paradigm. Eur. J. Neurosci. 23, 2495-2504 (2006). (Pubitemid 43742880)
22. Crestani F, Lorez M, Baer K et al. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nature Neurosci. 2, 833-839 (1999). (Pubitemid 30491177)
23. Petty F. GABA and mood disorders: a brief review and hypothesis. J. Affect. Disord. 34, 275-281 (1995).
24. Blum BP, Mann JJ. The GABAergic system in schizophrenia. Int. J. Neuropsychopharmacol. 5, 159-179 (2002). (Pubitemid 34662978)
25. Wassef A, Baker J, Kochan LD. GABA and schizophrenia: a review of basic science and clinical studies. J. Clin. Psychopharmacol. 23, 601-640 (2003). (Pubitemid 37443192)
26. Lanctôt KL, Herrmann N, Mazzotta P, Khan LR, Ingber N. GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can. J. Psychiatry 49, 439-453 (2004). (Pubitemid 39071365)
27. Rissman RA, De Blas AL, Armstrong DM. GABAA receptors in aging and Alzheimer's disease. J. Neurochem. 103, 1285-1292 (2007). (Pubitemid 47631802)
28. Caraceni T, Calderini G, Consolazione A et al. Biochemical aspects of Huntington's chorea. J. Neurol. Neurosurg. Psychiatry 40, 581-587 (1977).
29. Cepeda C, Starling AJ, Wu N et al. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. J. Neurosci. Res. 78, 855-867 (2004). (Pubitemid 39657573)
30. Johnston GAR, Chebib M, Hanrahan JR, Mewett KN. Neurochemicals for the investigation of GABA-c receptors. Neurochem. Res. 35(12), 1970-1977 (2010).
31. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol. Sci. 21, 16-19 (2000).
32. Chebib M, Johnston GAR. The 'ABC' of GABA receptors: a brief review. Clin. Exp. Pharmacol. Physiol. 26, 937-940 (1999). (Pubitemid 29513638)
33. Chebib M, Johnston GAR. GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology. J. Med. Chem. 43, 1427-1447 (2000). (Pubitemid 30238425)
34. Johnston GAR. Medicinal chemistry and molecular pharmacology of GABAC receptors. Curr. Top. Med. Chem. 2, 903-913 (2002).
35. Connolly CN, Wafford KA. The cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function. Biochem. Soc. Trans. 32, 529-534 (2003).
36. Carter CR, Kozuska JL, Dunn SM. Insights into the structure and pharmacology of GABAA receptors. Future Med. Chem. 2(5), 859-887 (2010).
37. Johnston GAR, Chebib M, Duke RK. Ionotropic GABA receptors: ligand gated ion channels. In:Control and Diseases of Sodium Dependent Transport Proteins and Ion Channels . Suketa Y, Carafoli E, Lazdunski M, Mikoshiba K, Okada Y, Wright E (Eds). Elsevier-Science B.V., MI, USA 369-372 (2000).
38. Le Novére N, Changeux J-P. The ligand gated ion channel database. Nucleic Acids Res. 27, 340-342 (1999). (Pubitemid 29209479)
39. Filippova N, Wotring VE, Weiss DS. Evidence that the TM1-TM2 loop contributes to the r1 GABA receptor pore. J. Biol. Chem. 279, 20906-20914 (2004). (Pubitemid 38656488)
40. Qian H, Ripps H. Focus on molecules: the GABAC receptor. Exp. Eye Res. 88, 1002-1003 (2009).
41. Barnard EA. Receptor classes and the transmitter-gated ion channels. Trends Biochem. Sci. 17, 368-374 (1992).
42. Absalom NL, Lewis TM, Schofield PR. Mechanisms of channel gating of the ligand-gated ion channel superfamily inferred from protein structure. Exp. Physiol. 89, 145-153 (2004). (Pubitemid 38379939)
43. Johnston GAR, Curtis DR, Beart PM, Gamer CJA, McCulloch RM, Twitchin B. Cis- and trans-4-aminocrotonic acid as GABA analogues of restricted conformation. J. Neurochem. 24, 157-160 (1975).
44. Drew CA, Johnston GAR, Weatherby RP. Bicuculline-insensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes. Neurosci. Lett. 52, 317-321 (1984). (Pubitemid 15186505)
45. Polanzani L, Woodward RM, Miledi R. Expression of mammalian γ-aminobutyric acid receptors with distinct pharmacology in xenopus oocytes. Proc. Natl Acad. Sci. USA 88, 4318-4322 (1991). (Pubitemid 21914531)
46. Cutting GR, Lu L, O'Hara BF et al. Cloning of the γ-aminobutyric acid (GABA) r1 cDNA: a GABA receptor subunit highly expressed in the retina. Proc. Natl Acad. Sci. USA. 88, 2673-2677 (1991). (Pubitemid 21916480)
47. Feigenspan A, Wässle H, Bormann J. Pharmacology of GABA receptor Cl- channels in rat retinal bipolar cells. Nature 361, 159-162 (1993). (Pubitemid 23031349)
48. Qian H, Dowling JE. Novel GABA responses from rod-driven retinal horizontal cells. Nature 361, 162-164 (1993). (Pubitemid 23031350)
49. Enz R. GABAC receptors: a molecular view. Biol. Chem. 382, 1111-1122 (2001).
50. Zhang D, Pan Z-H, Awobuluyi M, Lipton SA. Structure and function of GABAC receptors: a comparison of native versus recombinant receptors. Trends Pharmacol. Sci. 22, 121-132 (2001). (Pubitemid 32181843)
51. Wang T-L, Guggino WB, Cutting GR. A novel γ-aminobutyric acid receptor subunit (r2) cloned from human retina forms bicuculline-insensitive homooligomeric receptors in xenopus oocytes. J. Neurosci. 14, 6524-6531 (1994). (Pubitemid 24333073)
52. Qian H, Dowling JE, Ripps H. Molecular and pharmacological properties of GABA-r subunits from white perch retina. J. Neurobiol. 37, 305-320 (1998). (Pubitemid 28478252)
53. Kusama T, Spivak CE, Whiting P, Dawson Vl, Schaeffer JC, Uhl GR. Pharmacology of GABA r1 and GABA a/b receptors expressed in Xenopus oocytes and COS cells. Br. J. Pharmacol. 109, 200-206 (1993). (Pubitemid 23113823)
54. Shingai R, Yanagi K, Fukushima T, Sakata K, Ogurusu T. Functional expression of GABA r3 receptors in Xenopus oocytes. Neurochem. Res. 26, 387-390 (1996). (Pubitemid 27010778)
55. Pan Y, Khalili P, Ripps H, Qian H. Pharmacology of GABAC receptors: responses to agonists and antagonists distinguish a- and b-subtypes of homomeric receptors expressed in Xenopus oocytes. Neurosci. Lett. 376, 60-65 (2005). (Pubitemid 40202938)
56. López-Chávez A, Miledi R, Martínez-Torres A. Cloning and functional expression of the bovine GABAC r2 subunit - molecular evidence of a widespread distribution in the CNS. Neurochem. Res. 53, 421-427 (2005). (Pubitemid 41643070)
57. Alakuijala A, Talvioja K, Pasternack A, Pasternack M. Functional characterization of rat r2 subunits expressed in HEK293 cells. Eur. J. Neurosci. 21, 692-700 (2005). (Pubitemid 40363504)
58. Amin J, Weiss DS. Homomeric r1 GABA channels: activation properties and domains. Receptors Channels 2, 227-236 (1994).
59. Boue-Grabot E, Roudbaraki M, Bascies L, Tramu G, Bloch B, Garret M. Expression of GABA receptor r subunits in rat brain. J. Neurochem. 70, 899-907 (1998). (Pubitemid 28113621)
60. Enz R, Cutting GR. GABAC receptor r subunits are heterogeneously expressed in the human cns and form homo- and heterooligomers with distinct physical properties. Eur. J. Neurosci. 11, 41-50 (1999). (Pubitemid 29012310)
61. Hackam AS, Wang T-L, Guggino WB, Cutting GR. Sequences in the amino termini of GABA r and GABAA subunits specify their selective interaction in vitro. J. Neurochem. 70, 40-46 (1998). (Pubitemid 28020826)
62. Qian H, Ripps H. Response kinetics and pharmacological properties of heteromeric receptors formed by coassembly of GABA r- and g2-subunits. Proc. R. Soc. Lond. B. 266, 2419-2425 (1999). (Pubitemid 30019045)
63. Ekema GM, Zheng W, Lu L. Interaction of GABA receptor/channel r1 and g2 subunit. Invest. Ophthalmol. Vis. Sci. 43, 2326-2333 (2002).
64. Qian H, Pan Y. Co-assembly of GABA r subunits with the GABAA receptor g2 subunit cloned from white perch retina. Mol. Brain Res. 103, 62-70 (2002). (Pubitemid 34775034)
65. Milligan CJ, Buckley NJ, Garret M, Deuchars J, Deuchars SA. Evidence for inhibition mediated by coassembly of GABAA and GABAC receptor subunits in native central neurons J. Neurosci. 24, 7241-7250 (2004). (Pubitemid 39100694)
66. Fletcher EL, Koulen P, Wässle H. GABAA and GABAC receptors on mammalian rod bipolar cells. J. Comp. Neurol. 396, 351-365 (1998). (Pubitemid 28264849)
67. Lukasiewicz PD, Wong ROL. The properties of GABA(c) receptors on ferret retinal bipolar cells. Invest. Ophthalmol. Vis. Sci. 37(3), 1940-1940 (1996).
68. Eggers ED, Lukasiewicz PD. GABA(A), GABA(C) and glycine receptor-mediated inhibition differentially affects light-evoked signalling from mouse retinal rod bipolar cells. J. Physiol. - London 572(1), 215-225 (2006).
69. Lukasiewicz PD. Synaptic mechanisms that shape visual signaling at the inner retina. Prog. Brain Res. 147, 205-218 (2005).
70. Lukasiewicz PD, Eggers ED, Sagdullaev BT, McCall MA. GABA(C) receptor-mediated inhibition in the retina. Vision Res. 44(28), 3289-3296 (2004).
71. Lukasiewicz PD, Shields CR. Different combinations of GABA(A) and GABA(C) receptors confer distinct temporal properties to retinal synaptic responses. J. Neurophysiol. 79(6), 3157-3167 (1998). (Pubitemid 28317042)
72. Rozzo A, Armellin M, Franzot J, Chiaruttini C, Nistri A, Tongiorgi E. Expression and dendritic mRNA localization of GABAC receptor r1 and r2 subunits in developing rat brain and spinal cord. Eur. J. Neurosci. 15, 1747-1758 (2002). (Pubitemid 35471900)
73. Ogurusu T, Shingai R. Cloning of a putative γ-aminobutyric acid (GABA) receptor subunit r3 cDNA. Biochim. Biophys. Acta 1305, 15-18 (1996).
74. Jansen A, Hoepfner M, Herzig K-H, Riecken E-O, Scherü bl H. GABAC receptors in neuroendocrine gut cells: a new GABA-binding site in the gut. Pflü gers Arch. - Eur. J. Physiol. 441, 294-300 (2000). (Pubitemid 32128170)
75. Fletcher EL, Clark MJ, Senior P, Furness JB. Gene expression and localisation of GABAC receptors in neurons of the rat gastrointestinal tract. Neurosci. 107, 181-189 (2001). (Pubitemid 34020695)
76. McCall MA, Lukasiewicz PD, Gregg RG, Peachey NS. Elimination of the r1 subunit abolishes GABAC receptor expression and alters visual processing in the mouse retina. J. Neurosci. 22, 4163-4174 (2002). (Pubitemid 37465723)
77. Schlicker K, McCall MA, Schmidt M. GABAC receptor-mediated inhibition is altered but not eliminated in the superior colliculus of GABAc r1 knockout mice. J. Neurophysiol. 101, 2947-2983 (2009).
78. Zheng W, Zhao X, Wang J, Lu L. Retinal vascular leakage occurring in GABA rho-1 subunit deficient mice. Exp. Eye Res. 90, 634-640 (2010).
79. Zheng W, Xie W, Zhang J et al. Function of γ-aminobutyric acid receptor/channel r1 subunits in spinal cord. J. Biol. Chem. 278, 48321-48329 (2003). (Pubitemid 37523287)
80. Chen Y, Zhou D, Zhou K et al. Study on olfactory function in GABAC receptor/ channel r1 subunit knockout mice. Neurosci. Lett. 427, 10-15 (2007). (Pubitemid 47599786)
81. Alakuijala A, Alakuijala J, Pasternack M. Evidence for a functional role of GABA receptors in the rat mature hippocampus. Eur. J. Neurosci. 23(2), 514-520 (2006).
82. Xu JY, Yang B, Sastry BR. The involvement of GABA-C receptors in paired-pulse depression of inhibitory postsynaptic currents in rat hippocampal CA1 pyramidal neurons. Exp. Neurol. 216(1), 243-246 (2009).
83. Boue-Grabot E, Taupignon A, Tramu G, Garret M. Molecular and electrophysiological evidence for a GABAC receptor in thyrotropin-secreting cells. Endocrinol. 141(5), 1627-1632 (2000). (Pubitemid 32274390)
84. Zizzo MG, Mule F, Serio R. Functional evidence for GABA as modulator of the contractility of the longitudinal muscle in mouse duodenum: role of GABA(A) and GABA(C) receptors. Neuropharmacol. 52(8), 1685-1690 (2007). (Pubitemid 46843144)
85. Chebib M, Hinton T, Schmid KL et al. Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory. J. Pharmacol. Exp. Ther. 328, 448-457 (2009).
86. Stone RA, Liu J, Sugimoto R, Capehart C, Zhu X, Pendrak K. GABA, experimental myopia, and ocular growth in chick. Invest. Ophthalmol. Vis. Sci. 44, 3933-3946 (2003). (Pubitemid 37047966)
87. Chebib M, Hanrahan JR, Mewett KN, Duke RK, Johnston GAR. Ionotropic GABA receptors as therapeutic targets for memory and sleep disorders. Annu. Rep. Med. Chem. 39, 13-23 (2004).
88. Deschaux O, Froestl W, Gottesmann C. Influence of a GABAB and GABAC receptor antagonist on sleep-waking cycle in the rat. Eur. J. Pharmcol. 535, 177-181 (2006).
89. Gamel-Didelon K, Kunz L, Föhr KJ, Gratz M, Mayerhofer A. Molecular and physiological evidence for functional γ-aminobutyric acid (GABA)-C receptors in growth hormone-secreting cells. J. Biol. Chem. 278, 20192-20195 (2003). (Pubitemid 36799215)
90. Feigenspan A, Bormann J. Differential pharmacology of GABAA and GABAC receptors on rat retinal bipolar cells. Eur. J. Pharmacol. 288, 97-104 (1994).
91. Bormann J, Feigenspan A. GABAC receptors. Trends Neurosci. 18, 515-519 (1995). (Pubitemid 3001838)
92. Chebib M, Mewett KN, Johnston GAR. GABA receptor antagonists differentiate between human r1 and r2 receptors expressed in xenopus oocytes. Eur. J. Pharmacol. 357, 227-234 (1998). (Pubitemid 28439199)
93. Johnston GAR, Chebib M, Hanrahan JR, Mewett KN. GABAC receptors as drug targets. Curr. Drug Targets - CNS Neurol. Disord. 2, 260-268 (2003).
94. Vien J, Duke RK, Mewett KN, Johnston GAR, Shingai R, Chebib M. Trans-4-amino-2-methylbut-2-enoic acid (2-meTACA) and (±)-trans-2- sminomethylcyc lopropanecarboxylic acid ((±)-TAMP) can differentiate rat r3 from human r1 and r2 recombinant GABAC receptors. Br. J. Pharmacol. 135, 883-890 (2002). (Pubitemid 34214446)
95. Johnston GAR. GABA receptor pharmacology. In:Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s . Cuello AC, Collier B (Eds). Birkhäuser Verlag, Basel, Switzerland 11-15 (1995).
96. Chebib M, Vandenberg RJ, Johnston GAR. Analogues of γ-aminobutyric acid (GABA) and trans-4-aminocrotonic acid (TACA) substituted in the 2 position as GABAC receptor antagonists. Br. J. Pharmacol. 122, 1551-1560 (1997). (Pubitemid 28000181)
97. Crittenden DL, Park A, Qiu J et al. Enantiomers of cis-constrained and flexible 2-substituted GABA analogues exert opposite effects at recombinant GABAC receptors. Bioorg. Med. Chem. 14, 447-455 (2006). (Pubitemid 41767604)
98. Allan RD, Johnston GAR. Synthetic analogs for the study of GABA as a neurotransmitter. Med. Res. Rev. 3, 91-118 (1983). (Pubitemid 13059323)
99. Hinton T, Chebib M, Johnston GAR. Enantioselective actions of 4-amino-3- hydroxybutanoic acid and (3-amino-2- hydroxypropyl)methylphosphinic acid at recombinant GABAC receptors. Bioorg. Med. Chem. Lett. 18, 402-404 (2008).
100. Allan RD, Curtis DR, Headley PM, Johnston GAR, Lodge D, Twitchin B. The synthesis and activity of cis- and trans-2- (aminomethyl)cyclopropanecarboxylic acid as conformationally restricted analogues of GABA. J. Neurochem. 34, 652-654 (1980). (Pubitemid 10165083)
101. Duke RK, Chebib M, Balcar VJ, Allan RD, Mewett KN, Johnston GAR. (+)- and (-)-cis-2-aminomethylcyclopropanecarboxylic acids show opposite pharmacology at recombinant r1 and r2 GABAC receptors. J. Neurochem. 75, 2602-2610 (2000).
102. Segal M, Sims K, Smissman E. Characterisation of an inhibitory receptor in rat hippocampus: a microiontophoretic study using conformationally restricted amino acid analogues. Br. J. Pharmacol. 54, 181-188 (1975).
103. Nicoll RA. The effect of conformationally restricted amino acid analogues on the frog spinal cord in vitro. Br. J. Pharmacol. 59, 303-309 (1977). (Pubitemid 8030840)
104. Allan RD, Johnston GAR, Twitchin B. Synthesis of analogues of GABA. III. All four stereoisomers of 3-aminocyclopentanecarboxylic acid and a stereochemical correlation with amidinomycin. Aust. J. Chem. 32, 2517-2521 (1979). (Pubitemid 10077753)
105. Allan RD, Dickenson HW, Fong J. Structure-activity studies on the activity of a series of cyclopentane GABA analogues on GABAA receptors and GABA uptake. Eur. J. Pharmcol. 122, 339-348 (1986). (Pubitemid 16061480)
106. Chebib M, Allan RD, Duke RK, Johnston GAR. The effects of cyclopentane and cyclopentene analogues of GABA at recombinant GABAC receptors. Eur. J. Pharmacol. 430, 185-192 (2001). (Pubitemid 33050037)
107. Kumar RJ, Chebib M, Hibbs DE et al. Novel γ-aminobutyric acid r1 receptor antagonists; synthesis, pharmacological activity and structure-activity relationships. J. Med. Chem. 51, 3825-3840 (2008). (Pubitemid 351956513)
108. Chebib M, Vandenberg RJ, Froestl W, Johnston GAR. Unsaturated phosphinic analogues of γ-aminobutyric acid as GABAC receptor antagonists. Eur. J. Pharmacol. 329, 223-229 (1997).
109. Kusama T, Wang T-L, Guggino WB, Cutting GR, Uhl GR. GABA r2 receptor pharmacological profile: GABA recognition site similarities to r1. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 245, 83-84 (1993). (Pubitemid 23085609)
110. Madsen C, Jensen AA, Liljefors T et al. 5-substituted imidazole-4-acetic acid analogues: synthesis, modeling, and pharmacological characterization of a series of novel γ-aminobutyric acid(C) receptor agonists. J. Med. Chem. 50(17), 4147-4161 (2007). (Pubitemid 47301746)
111. Krehan D, Frølund B, Ebert B et al. Aza-thip and related analogues of thip as GABAC antagonists. Bioorg. Med. Chem. 11, 4891-4896 (2003). (Pubitemid 37352975)
112. Allan RD, Dickenson HW, Johnston GAR, Kazlauskas R, Mewett KN. Structural analogues of ZAPA as GABAA agonists. Neurochem. Int. 30, 583-591 (1997). (Pubitemid 27187229)
113. Woodward RM, Polanzani L, Miledi R. Characterization of bicuculline/baclofen-insensitive (r-like) γ-aminobutyric acid receptors expressed in Xenopus oocytes II. Pharmacology of γ-aminobutyric acidA and γ-aminobutyric acidB receptor agonists and antagonists. Mol. Pharmacol. 43, 609-625 (1993). (Pubitemid 23112739)
114. Allan RD, Twitchin B. Synthesis of analogues of GABA. IV. Three unsaturated derivatives of 3-aminocyclopentane-1-carboxylic acid. Aust. J. Chem. 33, 599-604 (1980). (Pubitemid 11236872)
115. Olpe H-R, Steinmann MW, Ferrat T et al. The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro. Eur. J. Pharmacol. 233, 179-186 (1993). (Pubitemid 23090054)
116. Froestl W, Mickel SJ, Von Sprecher G et al. Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists. J. Med. Chem. 38, 3313-3331 (1995).
117. Chowdhury S, Muni NJ, Greenwood NP, Pepperberg DR, Standaert RF. Phosphonic acid analogs of GABA through reductive dealkylation of phosphonic diesters with lithium trialkylborohydrides. Bioorg. Med. Chem. Lett. 17, 3745-3748 (2007). (Pubitemid 46898800)
118. Murata Y, Woodward RM, Miledi R, Overman LE. The first selective antagonists for a GABAC receptor. Bioorg. Med. Chem. Lett. 6, 2073-2076 (1996).
119. Hanrahan JR, Mewett KN, Chebib M, Burden PM, Johnston GAR. An improved, versatile synthesis of the GABAc antagonists (1,2,5,6-tetrahydropyridin-4-yl) methylphosphinic acid (TPMPA) and (piperidin-4-yl)methylphosphinic acid (P4MPA). J. Chem. Soc. Perkin Trans. 1, 2389-2392 (2001).
120. Dumond YR, Montchamp J-L. Palladium-catalysed cross-coupling reaction of anilinium hypophosphite with alkenyl bromides and triflates: Application to the synthesis of GABA analogues. J. Organomet. Chem. 653, 252-260 (2002). (Pubitemid 34594520)
121. Ragozzino D, Woodward RM, Murata Y, Eusebi F, Overman LE, Miledi R. Design and in vitro pharmacology of a selective γ-aminobutyric acidc receptor antagonist. Mol. Pharmacol. 50, 1024-1030 (1996). (Pubitemid 26347725)
122. Chebib M, Hanrahan JR, Kumar RJ et al. (3-aminocyclopentyl) methylphosphinic acids: novel GABAc receptor antagonists. Neuropharmacol. 52, 779-787 (2007). (Pubitemid 46237639)
123. Krehan D, Frølund B, Krogsgaard-Larsen P, Kehler J, Johnston GAR, Chebib M. Phosphinic, phosphonic and seleninic acid bioisosteres of isonipecotic acid as novel and selective GABAC receptor antagonists. Neurochem. Int. 42, 561-565 (2003). (Pubitemid 36183664)
124. Hanrahan JR, Mewett KN, Chebib M et al. Diastereoselective synthesis of (±)-(3-aminocyclopentane)alkylphosphinic acids, conformationally restricted analogues of GABA. Org. Biomol. Chem. 4, 2642-2649 (2006). (Pubitemid 43952821)
125. Chebib M. GABAC receptor ion channels. Clin. Exp. Pharmacol. Physiol. 31, 800-804 (2004).
126. Chebib M, Gavande N, Wong KY et al. Guanidino acids act as r1 GABA(C) receptor antagonists. Neurochem. Res. 34, 1704-1711 (2009).
127. Gavande N, Yamamoto I, Salam NK et al. Novel cyclic phosphinic acids as GABAC r receptor antagonists: design, synthesis, and pharmacology. Med. Chem. Lett. 2(1), 11-16 (2010).
128. Vu TQ, Chowdhury S, Muni NJ, Qian H, Standaert RF, Pepperberg DR. Activation of membrane receptors by a neurotransmitter conjugate designed for surface attachment. Biomaterials 26(14), 1895-1903 (2005). (Pubitemid 39575331)
129. Gussin HA, Tomlinson ID, Little DM et al. Binding of muscimol-conjugated quantum dots to GABA-c receptors. J. Am. Chem. Soc. 128(49), 15701-15713 (2006). (Pubitemid 44894111)
130. Wu SM, Qiao X, Nobels JL, Yang XL. Localization and modulatory actions of zinc in vertebrate retina. Vision Res. 33, 2611-2616 (1993). (Pubitemid 23354557)
131. Calvo D, Vazquez AE, Miledi R. Cationic modulation of r1-type g-aminobutyrate receptors expressed in xenopus oocytes. Proc. Natl Acad. Sci. USA 91, 12725-12729 (1995).
132. Morris K, Moorefield CN, Amin J. Differential modulation of the γ-aminobutyric acid type C receptor by neuroactive steroids. Mol. Pharmacol. 56, 752-759 (1999). (Pubitemid 29491177)
133. Li W, Jin X, Covey DF, Steinbach JH. Neuroactive steroids and human recombinant r1 GABAC receptors. J. Pharmacol. Exp. Ther. 323, 236-247 (2007). (Pubitemid 47443275)
134. Thomet U, Baur R, Dodd RH, Sigel E. Loreclezole as a simple functional marker for homomeric r type GABA receptors. Eur. J. Pharmcol. 408, R1-R2 (2000).
135. Goutman JD, Waxemberga MD, Doñate-Oliver F, Pomataa PE, Calvo DJ. Flavonoid modulation of ionic currents mediated by GABAA and GABAC receptors. Eur. J. Pharmcol. 461, 79-87 (2003). (Pubitemid 36174025)
136. Froestl W, Gallagher M, Jenkins H et al. SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochem. Pharmacol. 68, 1479-1487 (2004). (Pubitemid 39286451)
137. Matsui K, Hasegawa J, Tachibana M. Modulation of excitatory synaptic transmission by GABA(C) receptor-mediated feedback in the mouse inner retina. J. Neurophysiol. 86(5), 2285-2298 (2001). (Pubitemid 34000591)
138. Denter DG, Heck N, Riedemann T, White R, Kilb W, Luhmann HJ. GABAC receptors are functionally expressed in the intermediate zone and regulate radial migration in the embryonic mouse neocortex. Neurosci. 167(1), 124-134 (2010).
139. Harvey VL, Duguid IC, Krasel C, Stephens GJ. Evidence that GABA rho subunits contribute to functional ionotropic GABA receptors in mouse cerebellar purkinje cells. J. Physiol. 577(Pt 1), 127-139 (2006). (Pubitemid 44698245)
140. Schmidt M, Boller M, Ozen G, Hall WC. Disinhibition in rat superior colliculus mediated by GABAc receptors. J. Neurosci. 21, 691-699 (2001). (Pubitemid 32107457)
141. Nakayama Y, Hattori N, Otani H, Inagaki C. Gamma-aminobutyric acid (GABA)-C receptor stimulation increases prolactin (PRL) secretion in cultured rat anterior pituitary cells. Biochem. Pharmacol. 71(12), 1705-1710 (2006).
142. Arnaud C, Gauthier P, Gottesmann C. Study of a GABAC receptor antagonist on sleep-waking behavior in rats. Psychopharmacol. 154, 415-419 (2001). (Pubitemid 32260902)
143. Reis GM, Duarte ID. Involvement of chloride channel coupled GABA(C) receptors in the peripheral antinociceptive effect induced by GABA(C) receptor agonist cis-4- aminocrotonic acid. Life Sci. 80, 1268-1273 (2007).
144. Klein RD, Brennan TJ: WO2002079380 (2002).
145. Chebib M, Johnston GAR, Hanrahan JR: WO200345897 (2003).
146. Chebib M, Kumar RJ, Johnston GAR, Hanrahan JR: WO2006000043 (2006).